{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:09:03Z","timestamp":1784549343105,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.urolonc.2026.110998","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T10:05:26Z","timestamp":1770372326000},"page":"110998","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Venous invasion in upper tract urothelial carcinoma: Diagnostic features and oncologic outcomes"],"prefix":"10.1016","volume":"44","author":[{"given":"Stephan","family":"Br\u00f6nimann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Moghimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Korn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezra","family":"Baraban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzad","family":"Sedaghat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9495-6983","authenticated-orcid":false,"given":"Nirmish","family":"Singla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.urolonc.2026.110998_bib0001","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0090-4295(96)00312-3","article-title":"Transitional cell carcinoma of the kidney with tumor thrombus into the vena cava","volume":"48","author":"Williams","year":"1996","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.urolonc.2026.110998_bib0002","doi-asserted-by":"crossref","DOI":"10.1186\/s12957-016-1041-z","article-title":"Transitional cell carcinoma with extension of the renal vein and IVC tumor thrombus: report of three cases and literature review","volume":"14","author":"Li","year":"2016","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.urolonc.2026.110998_bib0003","first-page":"1","article-title":"Sarcomatoid variant of urothelial carcinoma of the renal Pelvis with inferior vena cava tumour thrombus: a case report and literature review","author":"Rashid","year":"2018","journal-title":"Case Rep Pathol"},{"key":"10.1016\/j.urolonc.2026.110998_bib0004","article-title":"Atypical presentations of UTUC: a case report of three patients","volume":"13","author":"Guo","year":"2023","journal-title":"Front Oncol"},{"issue":"7","key":"10.1016\/j.urolonc.2026.110998_bib0005","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.21037\/tau-21-253","article-title":"Urothelial carcinoma of the renal pelvis with renal vein and inferior vena cava tumor thrombus: case series and literature review","volume":"10","author":"Tian","year":"2021","journal-title":"Transl Androl Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2026.110998_bib0006","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1590\/S1677-55382009000100004","article-title":"The role of liver transplantation techniques in the surgical management of advanced renal urothelial carcinoma with or without inferior vena cava thrombus","volume":"35","author":"Cerwinka","year":"2009","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.urolonc.2026.110998_bib0007","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7386140","article-title":"Prognostic value of lymphovascular invasion in upper urinary tract urothelial carcinoma after radical nephroureterectomy: a systematic review and meta-analysis","author":"Liu","year":"2019","journal-title":"Dis Markers"},{"key":"10.1016\/j.urolonc.2026.110998_bib0008","first-page":"1","article-title":"UICC. TNM classification of malignant tumours, 8 th edition due December 2016","author":"Brierley","year":"2017","journal-title":"Union Int Can Control"},{"issue":"5","key":"10.1016\/j.urolonc.2026.110998_bib0009","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.eururo.2022.07.002","article-title":"The 2022 World Health Organization classification of tumors of the urinary system and male genital organs-Part B: prostate and urinary tract tumors","volume":"82","author":"Netto","year":"2022","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2026.110998_bib0010","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The clavien-dindo classification of surgical complications: five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.urolonc.2026.110998_bib0011","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.celrep.2019.04.048","article-title":"Dysregulation of EMT drives the progression to clinically aggressive sarcomatoid bladder cancer","volume":"27","author":"Guo","year":"2019","journal-title":"Cell Rep"},{"issue":"5","key":"10.1016\/j.urolonc.2026.110998_bib0012","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.urolonc.2026.110998_bib0013","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nrc.2017.118","article-title":"EMT in cancer","volume":"18","author":"Brabletz","year":"2018","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.urolonc.2026.110998_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-25918-4","article-title":"Determinants of renal cell carcinoma invasion and metastatic competence","volume":"12","author":"Kim","year":"2021","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.urolonc.2026.110998_bib0015","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1007\/s00261-019-02173-2","article-title":"Upper urinary tract urothelial carcinoma on multidetector CT: spectrum of disease","volume":"44","author":"Ali","year":"2019","journal-title":"Abdom Radiol"},{"issue":"8","key":"10.1016\/j.urolonc.2026.110998_bib0016","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1200\/JCO.22.00763","article-title":"Multicenter phase II clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy for patients with high-grade upper tract urothelial carcinoma","volume":"41","author":"Coleman","year":"2023","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.urolonc.2026.110998_bib0017","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/JU.0000000000000644","article-title":"Phase II trial of neoadjuvant systemic chemotherapy followed by extirpative surgery in patients with high grade upper tract urothelial carcinoma","volume":"203","author":"Margulis","year":"2020","journal-title":"J Urol"},{"issue":"7","key":"10.1016\/j.urolonc.2026.110998_bib0018","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41585-023-00847-7","article-title":"Molecular profile of bladder cancer progression to clinically aggressive subtypes","volume":"21","author":"Guo","year":"2024","journal-title":"Nat Rev Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2026.110998_bib0019","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/JU.0000000000000761","article-title":"Histological subtypes and response to PD-1\/PD-L1 blockade in advanced urothelial cancer: a retrospective study","volume":"204","author":"Miller","year":"2020","journal-title":"J Urol"},{"issue":"8","key":"10.1016\/j.urolonc.2026.110998_bib0020","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/PAI.0000000000000938","article-title":"Expression of nectin-4 in bladder urothelial carcinoma, in morphologic variants, and nonurothelial histotypes","volume":"29","author":"Hoffman-Censits","year":"2021","journal-title":"Appl Immunohistochem Molecul Morphol"},{"issue":"3","key":"10.1016\/j.urolonc.2026.110998_bib0021","doi-asserted-by":"crossref","DOI":"10.1200\/EDBK_438640","article-title":"Current advances in the management of nonurothelial subtypes of bladder cancer","volume":"44","author":"Vlachou","year":"2024","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.urolonc.2026.110998_bib0022","article-title":"Neoadjuvant and Adjuvant chemotherapy for variant histology bladder cancers: a systematic review and meta-analysis","volume":"12","author":"Zhu","year":"2022","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.urolonc.2026.110998_bib0023","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3233\/BLC-240008","article-title":"Neoadjuvant cisplatin, gemcitabine, and docetaxel in sarcomatoid bladder cancer: clinical activity and whole transcriptome analysis","volume":"10","author":"Johnson","year":"2024","journal-title":"Bladder Cancer"},{"issue":"4_suppl","key":"10.1016\/j.urolonc.2026.110998_bib0024","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1200\/JCO.2024.42.4_suppl.652","article-title":"Outcomes with enfortumab vedotin in patients with advanced urothelial carcinoma and histology variants: analysis of the UNITE study","volume":"42","author":"Jindal","year":"2024","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.urolonc.2026.110998_bib0025","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1080\/14712598.2021.1929168","article-title":"Targeting nectin-4 by antibody-drug conjugates for the treatment of urothelial carcinoma","volume":"21","author":"Wong","year":"2021","journal-title":"Expert Opin Biol Ther."},{"key":"10.1016\/j.urolonc.2026.110998_bib0026","doi-asserted-by":"crossref","unstructured":"Bajorin D.F., Witjes J.A., Gschwend J.E., Schenker M., Valderrama B.P., Tomita Y., et al. Adjuvant nivolumab versus placebo in muscle-invasive urothelial carcinoma. 2021 Accessed October 20, 2021; 384(22):2102\u201314. , Available from: https:\/\/www.nejm.org doi: 10.1056\/NEJMoa2034442","DOI":"10.1056\/NEJMoa2034442"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926000086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926000086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:51:24Z","timestamp":1784548284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143926000086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1078143926000086"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.110998","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Venous invasion in upper tract urothelial carcinoma: Diagnostic features and oncologic outcomes","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.110998","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110998"}}